When it comes to clinical trial recruitment and retention, pharmaceutical companies face challenges that exacerbate the overall financial cost of drug development. Addressing the patient’s voice in trial design is key. Although patient-focused primary research and simulations are recognized ways of gathering input from patients, the former doesn’t necessarily allow for deep insights and in-person simulations have logistical challenges, especially during the pandemic. This is where virtual reality (VR) can come into play, offering patients and caretakers a truly immersive experience from the comfort of their homes, and cutting down on cost and time.
Additionally, VR can be an immersive and engaging way to inform patient/caregiver decision-making about participating in a clinical trial. Imagine: Physicians can now use VR as a powerful educational tool, enabling patients and caregivers to actually see and experience what the trial will entail.